patient
coinfect
surprisingli
present
benign
clinic
outcom
knowledg
chang
host
homeostat
equilibrium
may
favor
patient
resist
copathogen
prompt
us
investig
whether
infect
could
influenc
life
cycl
vitro
show
exposur
epitheli
cell
viral
particl
enhanc
content
result
decreas
influenza
replic
event
depend
tolllik
receptor
moreov
knockdown
prevent
abil
inhibit
replic
infect
also
increas
level
human
primari
macrophag
almost
consequ
arriv
influenza
ribonucleoprotein
rnp
nucleu
macrophag
inhibit
evalu
differ
approach
reduct
influenza
rnp
entri
nucleu
toll
life
cycl
macrophag
earlier
usual
limit
influenza
abil
induc
tnfa
judg
analysi
influenza
hemagglutin
ha
gene
vitro
experi
sampl
coinfect
individu
reduct
influenza
replic
result
delay
viral
evolut
result
may
provid
insight
mechan
may
attenu
clinic
cours
influenza
coinfect
patient
recent
influenza
acut
respiratori
tract
infect
great
impact
public
health
sinc
major
caus
morbid
mortal
among
respiratori
virus
influenza
one
import
pathogen
due
season
continu
pandem
threat
negativesenserna
orthomixoviru
enter
cell
bind
sialic
acid
residu
follow
endocytosi
fusion
viral
envelop
endocyt
membran
viral
ribonucleoprotein
rnp
compos
rna
polymeras
complex
viral
rna
nucleoprotein
np
nuclear
export
protein
nep
releas
transport
cell
nucleu
transcript
replic
viral
genom
take
place
next
viral
rnp
transport
nucleu
host
cell
plasma
membran
final
step
viru
assembl
virion
bud
occur
activ
influenza
replic
cycl
carri
human
epitheli
surfac
respiratori
tract
repres
largest
interfac
ga
exchang
play
key
role
fluid
ion
transport
well
surfact
product
influenza
infect
also
trigger
home
blood
monocyt
respiratori
tract
differenti
macrophag
capabl
produc
inflammatori
mediat
cytokin
type
interferon
tumor
necrosi
factora
tnfa
chemokin
respons
infect
macrophag
suscept
influenza
infect
viral
protein
made
infecti
viru
progeni
made
thu
influenzainfect
macrophag
endow
janusfac
orchestr
host
immun
respons
may
releas
cytokin
atyp
fashion
lead
influenzainduc
cytokin
storm
polar
one
condit
could
highli
influenc
presenc
differ
stimuli
respiratori
tract
pathogenassoci
molecular
pattern
pamp
could
activ
tolllik
receptor
tlr
infect
human
immunodefici
viru
type
causal
agent
acquir
immunodefici
syndrom
aid
affect
approxim
million
peopl
worldwid
number
continu
grow
infect
provok
progress
loss
cell
viru
cellularand
immun
activationdepend
mechan
eventu
collaps
immun
system
impos
new
homeostat
equilibrium
human
host
replic
differ
anatom
compart
gastrointestin
tract
lymph
node
lung
establish
numer
viru
sanctuari
surfac
glycoprotein
viral
product
may
even
affect
cell
suscept
infect
promiscu
bind
numer
cellsurfac
molecul
trigger
differ
event
cell
death
wherea
cell
interact
tissu
abnorm
gutassoci
lymphoid
tissu
galt
well
known
fate
infect
replic
respiratori
tract
remain
poorli
understood
contrast
increas
mortal
observ
immunocompromis
individu
cancer
transplant
patient
affect
emerg
influenza
individu
present
benign
clinic
outcom
instanc
barchi
et
al
found
clinic
outcom
individu
infect
differ
immunocompet
patient
ormsbi
et
al
report
subject
progress
immun
defici
typic
aid
present
increas
mortal
therefor
plausibl
hypothes
coinfect
new
homeostat
balanc
must
impos
host
exampl
compon
innat
immun
prove
significantli
contribut
effect
control
viral
infect
interferoninduc
cellular
restrict
factor
eg
interferoninduc
transmembran
protein
may
target
influenza
studi
show
influenza
replic
attenu
coinfect
experiment
assay
viral
particl
viral
surfac
glycoprotein
reduc
replic
fashion
consist
decreas
influenza
replic
evolut
delay
presenc
vitro
experi
individu
coinfect
virus
phenomenon
may
correl
mild
influenza
outcom
clinic
episod
coinfect
thu
report
first
time
interfer
replic
cycl
arrest
influenza
evolut
attenu
viral
replic
result
may
contribut
explain
mild
influenza
infect
observ
patient
coinfect
influenza
research
ethic
committe
evandro
chaga
clinic
research
institut
http
wwwipecfiocruzbrcgi
cgiluaexesysstarthtm
sid
led
dr
camillocoura
approv
retrospect
use
sampl
clinic
data
coinfect
individu
protocol
number
need
inform
consent
waiv
data
analys
anonym
fashion
human
epitheli
cervic
cancer
hela
madindarbi
canin
kidney
mdck
cell
cultur
dulbecco
modifi
eagl
medium
dmem
lgc
biotecnologia
paulo
brazil
minimum
essenti
eagl
medium
mem
lgc
biotecnologia
respect
supplement
fetal
bovin
serum
fb
hyclon
logan
ut
usa
uml
penicillin
mgml
streptomycin
sigmaaldrich
cell
cultur
co
atmospher
monocytederiv
macrophag
obtain
plastic
adher
peripher
blood
mononuclear
cell
pbmc
previous
isol
densiti
gradient
centrifug
ficollpaqu
ge
healthcar
buffi
coat
prepar
blood
healthi
donor
briefli
pbmc
plate
onto
plate
nalgenunc
dmem
contain
human
serum
hs
milliipor
penicillinstreptomycin
cell
maintain
standard
cultur
condit
day
monocyt
differenti
macrophag
nonadher
cell
wash
remain
macrophag
layer
maintain
dmem
hs
macrophag
puriti
determin
flow
cytometr
analysi
facscan
becton
dickinson
use
bd
bioscienc
southern
biotech
monoclon
antibodi
assay
macrophag
prepar
plastic
cultur
bottl
pbmc
previous
seed
ml
medium
per
bottl
cell
infect
assay
perform
influenza
amina
strain
isol
brazilian
patient
brazilian
nation
influenza
centerwho
pandem
isol
strain
monocytotrop
isol
bal
donat
aid
research
refer
reagent
program
divis
aid
nation
institut
allergi
infecti
diseas
nation
institut
health
nih
bethesda
md
influenza
viru
expand
mdck
cell
isol
expand
phytohemagglutininactiv
pbmc
viral
stock
aliquot
store
studi
effect
viru
infect
macrophag
hela
cell
viabil
evalu
h
cell
exposur
differ
viru
moi
use
reduct
inner
salt
xtt
sigma
assay
describ
condit
medium
influenza
growth
mock
use
control
proport
influenzacontain
medium
addit
viabil
hela
cell
expos
condit
also
determin
trypan
blue
dye
exclus
assay
viabil
hela
cell
macrophag
condit
describ
macrophag
infect
expos
overnight
viral
suspens
contain
ngml
antigen
ag
nonintern
virus
remov
wash
cell
monolay
replenish
fresh
medium
everi
day
necessari
approxim
medium
replac
fresh
medium
influenza
correspond
mock
infect
ad
uninfect
macrophag
day
infect
differ
moi
period
time
altern
hela
cell
seed
plate
cell
well
infect
differ
moi
h
co
monolay
treat
dmem
contain
fb
suspens
ngml
ag
unless
otherwis
mention
recombin
mgml
tat
ngml
oxid
tat
tatox
ifnc
ngml
influenza
titer
quantifi
cell
supernat
day
infect
specif
experi
influenzainfect
uninfect
hela
cell
treat
control
isotyp
solubl
antiretrovir
enfuvirtid
minut
prior
exposur
antibodi
purchas
invivogen
use
mgml
blocker
entri
receiv
donat
nih
aid
reagent
program
use
nm
mgml
respect
product
evalu
cellcultur
supernat
commerci
enzymelink
immunosorb
assay
elisa
kit
accord
manufactur
instruct
zeptometrix
rna
detect
describ
elsewher
titer
influenza
supernat
cultur
measur
mdck
cell
quantifi
real
time
rtpcr
reagent
real
time
rtpcr
includ
primer
probe
enzym
use
recommend
viru
quantif
base
standard
curv
method
describ
elsewher
modif
brief
real
time
rtpcr
rna
experiment
assay
run
parallel
serial
dilut
plasmid
novagen
contain
influenza
ha
synthet
gene
insert
genescript
flank
xhoi
hindii
restrict
site
quantif
express
copiesml
http
celsuri
edugsccndnahtml
neg
control
without
templat
includ
reaction
quantifi
total
influenza
rna
mrna
macrophag
lyse
h
pi
rna
extract
commerci
kit
rneasi
mini
kit
qiagen
cdna
synthet
superscript
iii
life
technolog
use
oligodt
life
technolog
primer
firststrand
synthesi
h
oligodtand
primer
allow
preferenti
retrotranscript
mrna
total
influenza
rna
respect
real
time
pcr
assay
perform
amplifi
influenza
gene
ha
gene
control
total
rna
mrna
measur
influenzainfect
macrophag
treat
ribavirin
kidney
donat
dr
nubia
boechat
farmamginho
fiocruz
immunoblot
assay
perform
quantifi
content
hela
cell
macrophag
expos
ngml
ag
mgml
ifnc
ng
ml
kept
standard
cultur
condit
differ
period
time
cell
lyse
laemmli
buffer
mm
trishcl
ph
bromophenol
blue
mm
bmercaptoethanol
sd
glycerol
mg
aliquot
extract
protein
qubit
protein
assay
kit
invitrogen
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
transfer
polyvinyliden
fluorid
filter
pvdf
hybondc
filter
block
incub
rabbit
polyclon
santa
cruz
biotechnolog
mous
polyclon
antibactin
antibodi
sigma
h
specif
reactiv
protein
detect
enhanc
chemiluminesc
method
use
ecl
kit
ge
heatlhcar
also
perform
densitometri
analysi
blot
use
imagej
softwar
version
densitometri
valu
initi
express
arbitrari
unit
calcul
mean
sem
next
densitometri
valu
control
band
medium
normal
therefor
valu
band
express
nfold
chang
throughout
articl
evalu
biolog
role
coinfect
perform
sirna
assay
previous
describ
briefli
hela
cell
plate
onto
plate
cell
transfect
sirna
life
technolog
scrambl
sequenc
concentr
nm
optimem
use
lipofectamin
sigma
h
transfect
cell
wash
infect
moi
cell
expos
overnight
cultur
supernat
harvest
quantifi
qrtpcr
parallel
cell
monolay
lyse
laemmli
buffer
western
blot
bactin
perform
macrophag
day
infect
inocul
moi
h
condit
allow
viru
adsorpt
cultur
wash
pb
lyse
buffer
mm
hepe
mm
mgcl
mmkcl
mm
dtt
mm
pmsf
parallel
assay
cell
wash
incub
warm
medium
h
follow
lyse
buffer
last
condit
enough
allow
influenza
rnp
reach
cell
nucleu
defin
sampl
earli
lysat
obtain
complet
one
replic
cycl
anoth
set
cell
instead
lyse
later
time
point
cell
initi
infect
describ
wash
incub
warm
cultur
medium
h
h
pi
cell
lyse
buffer
earli
late
lysat
centrifug
min
g
allow
separ
nuclear
pellet
nonnuclear
fraction
supernat
consid
endpoint
analysi
studi
arriv
influenza
rnp
nuclei
macrophag
confirm
puriti
nuclear
rna
prepar
nuclear
fraction
prepar
describ
express
housekeep
gene
gapdh
rnase
p
bactin
long
noncod
rna
lncrna
analyz
brief
rna
extract
perform
rneasi
mini
kit
cdna
synthet
superscript
iii
use
oligodt
primer
describ
perform
real
time
pcr
assay
syber
green
master
mix
use
ml
cdna
cycl
condit
describ
elsewher
primer
describ
tabl
lncrna
exclus
express
nuclear
fraction
base
literatur
result
figur
mean
crosscontamin
rna
nonnuclear
fraction
nuclear
prepar
unlik
occur
pbmc
cell
seed
onto
aclar
plastic
coverslip
proplast
inc
linden
nj
usa
h
plate
previous
coat
rattail
collagen
period
time
unadher
cell
wash
macrophag
allow
differenti
day
infect
nd
day
infect
cell
infect
influenza
moi
differ
period
time
cell
wash
pb
fix
paraformaldehyd
min
permeabil
tritonx
min
primari
antibodi
mous
igg
nih
aid
reagent
program
antiinfluenza
np
rabbit
igg
abcam
usa
incub
h
incub
cell
rins
three
time
incub
alexa
fluor
alexa
fluor
secondari
antibodi
goat
antirabbit
goat
antimous
igg
molecular
probe
usa
h
nuclei
stain
dapi
mgml
nacl
wash
min
nacl
specimen
mount
glycerol
npropyl
gallat
dabco
octan
paraphenylenediamin
sigma
imag
analyz
fiji
softwar
imagej
http
imagejnihgovij
control
experi
perform
without
antibodi
monitor
background
sign
aclar
coverslip
examin
axio
imag
microscop
phasecontrast
optic
carl
zeiss
germani
imag
acquir
olympu
digit
camera
olympu
japan
nasopharing
aspir
swab
npa
patient
confirm
diagnosi
coinfect
collect
individu
attend
brazilian
nation
influenza
surveil
program
differ
region
countri
collect
npa
sent
brazilian
nation
influenza
center
laboratorybas
diagnosi
confirm
real
time
rtpcr
assay
hemagglutinin
ha
gene
sequenc
phylogenet
analysi
rna
extract
cell
cultur
supernat
npa
subject
onestep
rtpcr
use
superscript
iii
platinum
taq
previous
describ
rtpcr
product
purifi
sequenc
perform
sanger
method
use
big
dye
termin
cycl
sequenc
readi
reaction
kit
appli
biosystem
fragment
analyz
use
automat
sequenc
abi
prismtm
genet
analyz
pe
appli
biosystem
consensu
sequenc
ha
gene
gener
seqscap
softwar
appli
biosystem
align
sequenc
deposit
genbank
use
clustalw
algorithm
megalign
mega
softwar
sequenc
analyz
use
neighborjoin
bootstrap
time
use
mega
suit
program
bootstrap
valu
greater
consid
signific
result
studi
prepar
use
excel
window
softwar
microsoft
least
three
independ
experi
mean
standard
error
mean
sem
display
statist
analysi
calcul
perform
use
softwar
comparison
mean
consid
significantli
differ
p
valu
less
mean
studentst
test
influenza
replic
epitheli
cell
respiratori
tract
influenzainfect
tissu
releas
bchemokin
rant
chemotact
blood
monocyt
monocyt
migrat
respiratori
tract
differenti
macrophag
may
particip
host
immun
respons
influenza
infect
individu
macrophag
sustain
viral
replic
even
presenc
antiretrovir
therapi
influenza
infect
macrophag
epitheli
cell
respiratori
tract
respect
thu
plausibl
influenzainfect
cell
expos
product
andor
viral
particl
anatom
site
evalu
whether
could
chang
influenza
replic
expos
hela
cell
surfac
glycoprotein
approxim
decreas
quantif
observ
influenzainfect
cell
expos
respect
figur
infect
influenza
viru
produc
presenc
also
reduc
approxim
figur
note
protein
could
secret
cell
tat
affect
influenza
replic
significantli
figur
b
moreov
effect
toward
influenza
replic
depend
retrovir
input
figur
inhibit
influenza
replic
due
exposur
hela
cell
differ
agent
cell
expos
remain
viabil
figur
result
therefor
suggest
product
present
extracellular
milieu
may
weaken
influenza
replic
expect
replic
hela
cell
figur
interferonc
ifnc
known
inhibitor
influenza
replic
use
posit
control
inhibit
replic
figur
although
entri
depend
upon
interact
viral
coreceptor
viral
glycoprotein
may
bind
multipl
molecul
cell
surfac
recent
demonstr
epitheli
cell
may
bind
tlr
agon
tlr
respiratori
tract
may
lead
ifnidepend
respons
demonstr
ifn
inhibit
influenza
replic
cell
cultur
laboratori
anim
restrict
factor
sinc
show
influenza
product
diminish
upon
exposur
cell
ifnc
figur
next
evalu
whether
inhibit
influenza
replic
would
depend
tlr
andor
influenzainfect
hela
cell
expos
presenc
block
antibodi
tlr
see
figur
antibodi
prevent
abil
inhibit
influenza
replic
note
control
isotyp
antibodi
influenc
impact
influenza
replic
importantli
prevent
inhibit
influenza
replic
wherea
figur
although
treatment
prevent
entri
could
block
interact
virtual
receptor
cell
surfac
hand
block
envelop
fusion
plasma
membran
prevent
transloc
mean
viral
free
interact
tlr
treatment
result
reinforc
surfac
glycoprotein
virion
may
inde
interact
nonclass
receptor
influenc
physiolog
cell
suscept
infect
next
measur
level
hela
cell
expos
ifnc
found
level
doubl
cell
expos
ifnc
enhanc
level
around
six
time
figur
consist
enhanc
level
prevent
treatment
either
antitlr
antibodi
figur
confirm
particip
inhibit
influenza
replic
perform
knock
assay
hela
cell
transfect
sirna
scrambl
control
scr
infect
expos
cultur
medium
h
influenza
infect
cell
supernat
monolay
harvest
quantifi
influenza
level
respect
figur
show
knock
absenc
top
panel
presenc
bottom
panel
prevent
increment
level
induc
retroviru
note
abil
enhanc
level
reinforc
figur
compar
top
bottom
panel
moreov
knock
led
increas
influenza
replic
three
time
figur
parallel
enhanc
figur
influenza
replic
drop
figur
hypothes
knockdown
prevent
abil
inhibit
influenza
replic
figur
although
influenza
undergo
product
life
cycl
macrophag
abl
adsorb
onto
penetr
produc
viral
protein
cell
infect
influenza
macrophag
could
orchestr
host
immun
respons
andor
produc
proinflammatori
cytokin
thu
subsequ
use
human
monocytederiv
macrophag
investig
whether
infect
could
chang
dynam
influenza
life
cycl
end
macrophag
inocul
differ
moi
evid
product
replic
search
daili
sign
infecti
influenza
progeni
observ
either
high
low
moi
figur
agreement
nonpermiss
macrophag
upon
influenza
infect
product
viral
replic
detect
assay
cell
therefor
differ
approach
use
macrophag
infect
influenza
moi
inoculum
remov
instead
differ
time
supernat
cultur
collect
remain
amount
measur
increment
influenza
amount
observ
detect
evalu
level
viral
rna
cultur
supernat
figur
titrat
mdck
figur
matter
fact
infect
origin
inoculum
drop
substanti
day
pi
figur
note
neither
influenza
inoculum
condit
medium
mdck
mockinfect
medium
cytotox
macrophag
figur
next
consid
primari
macrophag
replic
peak
around
day
influenza
infect
inoculum
remain
constant
three
day
exposur
cell
perform
coinfect
assay
macrophag
macrophag
day
infect
expos
moi
day
amount
infect
influenza
recov
supernat
monitor
found
rna
level
figur
infect
mdck
figur
decreas
respect
supernat
macrophag
result
consist
reproduc
macrophag
eight
differ
healthi
donor
although
macrophag
human
cell
type
could
infect
influenza
viru
simultan
absenc
product
infect
cell
may
limit
mechanist
analys
nevertheless
influenza
viru
shown
diminish
infect
presenc
find
seem
consist
mild
clinic
outcom
coinfect
individu
subsequ
evalu
whether
infect
also
enhanc
human
primari
macrophag
infect
augment
three
time
macrophag
level
detect
day
infect
rel
content
uninfect
cell
fig
note
tri
perform
sirna
assay
knockdown
macrophag
howev
knockdown
effici
vari
sever
donor
donor
preclud
mechanist
analyz
base
strategi
nevertheless
shown
restrict
influenza
life
cycl
prevent
arriv
viral
ribonucleoprotein
rnp
host
cell
nucleu
measur
level
bound
plasma
membran
amount
viral
rnp
reach
nucleu
macrophag
earli
late
time
point
synchron
influenza
infect
measur
influenza
rna
level
macrophag
nuclear
nonnuclear
fraction
see
materi
method
detail
consist
mechan
action
penetr
nucleu
reduc
macrophag
figur
pellet
fraction
earli
lysi
signific
chang
adsorpt
observ
macrophag
figur
supernat
fraction
earli
lysi
later
time
point
addit
macrophag
increas
level
influenza
rna
detect
nonnuclear
cell
fraction
figur
supernat
late
lysi
concomit
low
amount
influenza
rna
found
nuclear
fraction
figur
pellet
late
lysi
increment
influenza
level
nonnuclear
fraction
consist
diminish
viru
infect
presenc
measur
titrat
mdck
figur
reason
imagin
presenc
viru
particl
would
enter
macrophag
way
nucleu
would
impair
limit
later
step
influenza
life
cycl
confirm
result
interpret
quantit
analysi
compar
distribut
nuclei
uninfect
macrophag
influenza
infect
macrophag
absenc
presenc
shown
figur
respect
respect
macrophag
infect
np
local
superfici
cell
alreadi
display
protein
nuclei
h
infect
figur
subsequ
np
nuclear
distribut
progress
increas
h
infect
figur
c
late
time
point
nuclear
local
np
intens
figur
respect
influenza
coinfect
macrophag
np
signal
found
within
nuclei
earli
time
point
figur
c
h
influenza
infect
np
observ
nuclei
macrophag
figur
also
diffus
throughout
cytoplasm
differ
observ
macrophag
infect
influenza
figur
altogeth
data
figur
suggest
influenza
rnp
progress
nuclei
macrophag
impaireddelay
exposur
increas
level
epitheli
cell
hela
cell
expos
ngml
ag
mgml
ifnc
ngml
use
posit
control
h
cell
monolay
lyse
laemmli
buffer
submit
blot
assay
protein
describ
materi
method
band
analyz
densitometri
use
imagej
softwar
blot
repres
figur
assay
basal
level
protein
shown
hela
cell
expos
cultur
medium
consid
analyz
total
rna
mrna
uninfect
macrophag
total
influenza
rna
level
increas
macrophag
despit
reduc
abil
reach
nuclei
figur
natur
present
context
influenza
rna
transcript
reduc
cell
figur
control
ribavirin
use
inhibit
mainli
influenza
transcript
figur
inset
subsequ
wonder
whether
due
earli
restrict
influenza
life
cycl
macrophag
abil
orthomyxoviru
induc
product
proinflamatori
cytokin
tnfa
would
impair
macrophag
infect
expos
influenza
level
tnfa
measur
see
figur
influenza
abil
enhanc
tnfa
level
reduc
macrophag
therefor
enhanc
level
macrophag
may
restrict
influenza
life
cycl
cell
could
also
prevent
influenzainduc
proinflamatori
cytokin
releas
investig
whether
npa
individu
posit
diagnosi
influenza
virus
could
detect
would
suggest
presenc
agent
anatom
site
inde
found
virus
genom
respiratori
sampl
coinfect
patient
display
tabl
codetect
around
suggest
could
influenc
influenza
evolut
analyz
influenza
genom
coinfect
experi
patient
sequenc
hemagglutinin
ha
gene
escap
ifncinduc
inhibit
chose
sequenc
gene
highest
evolut
rate
amongst
influenza
gene
experiment
infect
assay
perform
quadrupl
produc
similar
ha
sequenc
repres
consensu
display
phylogenet
tree
compar
parent
strain
figur
analysi
translat
nucleotid
sequenc
reveal
evolut
viru
slower
presenc
ifnc
observ
viru
cultur
presenc
medium
figur
highlight
cell
expos
ngml
ag
h
influenza
infect
monolay
lyse
laemmli
buffer
submit
blot
assay
protein
bactin
housekeep
top
panel
cell
expos
bottom
panel
cell
expos
b
level
cultur
supernat
quantifi
qrtpcr
yaxi
immunoblot
band
analyz
densitometri
use
imagej
softwar
nfold
chang
au
score
black
squar
zaxi
panel
repres
three
independ
experi
influenza
replic
sirna
vs
medium
scr
treat
cell
expos
influenza
replic
vs
nonexpos
cell
medium
scr
influenza
replic
sirna
vs
medium
scr
treat
cell
expos
induc
inhibit
replic
result
impair
influenza
evolut
note
differ
viru
evolut
among
experiment
group
small
sinc
presenc
cellculturederiv
chang
comparison
parent
virus
vaccin
strain
amina
primari
isol
forc
sequenc
cluster
togeth
next
analyz
ha
sequenc
virus
collect
individu
tabl
compar
specimen
collect
seroneg
individu
period
juli
th
august
th
geograph
region
southern
brazil
rio
de
janeiro
see
figur
viru
coinfect
individu
figur
circl
phylogenet
closer
vaccin
strainindex
case
pandem
sampl
period
region
evolut
virus
individu
seem
impair
compar
sampl
similar
geograph
region
time
period
figur
consequ
specif
pattern
mutat
exist
cluster
sequenc
coinfect
individu
togeth
figur
circl
except
small
cluster
influenza
sequenc
southern
brazil
figur
see
influenza
strain
ario
grand
ario
grand
sul
asanta
regard
specif
mutat
ha
sequenc
coinfect
individu
compar
other
mild
fatal
case
specimen
possibl
observ
brazilian
strain
chang
mention
three
strain
southern
brazil
chang
reduc
influenza
evolut
presenc
may
reflect
compromis
replic
may
correl
mild
clinic
outcom
coinfect
individu
live
differ
region
world
increas
worldwid
mortal
observ
influenza
pandem
especi
group
patient
higher
risk
individu
immunocompromis
cancer
transplant
surprisingli
individu
present
benign
clinic
outcom
infect
unless
aid
although
figur
recoveri
influenza
macrophag
expos
macrophag
expos
moi
differ
day
exposur
influenza
viru
quantifi
qrtpcr
ha
gene
cell
cultur
supernat
n
b
mdck
cell
infect
cultur
supernat
collect
differ
time
macrophag
moi
influenza
titter
n
c
macrophag
expos
moi
moi
mock
infect
cell
viabil
assess
xtt
techniqu
three
day
influenza
exposur
n
empir
explan
rais
clarifi
phenomenon
antia
activ
antiretrovir
drug
enhanc
medic
attent
paid
patient
possibl
concomit
infect
may
attenu
replic
influenza
viru
thu
mitig
infect
clinic
cours
systemat
evalu
sinc
report
infect
may
lead
host
new
homeostat
equilibrium
confer
resist
copathogen
evalu
studi
whether
infect
could
interfer
influenza
life
cycl
studi
repres
challeng
approach
agent
primarili
infect
differ
cell
type
nevertheless
relev
insight
made
may
contribut
understand
better
outcom
clinic
episod
coinfect
brief
inhibit
replic
epitheli
cell
fashion
primari
macrophag
epitheli
cell
consequ
decreas
replic
presenc
impair
influenza
evolut
observ
vitro
experi
coinfect
patient
find
may
correl
mild
clinic
cours
influenza
infect
found
coinfect
individu
sinc
respiratori
tract
individu
may
colon
opportunist
inde
rare
pathogen
pneumocysti
carinii
p
jiroveci
anatom
site
hardli
think
abl
alberg
influenza
coinfect
also
show
virus
found
respiratori
secret
coinfect
host
consid
influenza
season
viru
may
infect
patient
mani
time
throughout
lifespan
individu
therefor
replic
may
influenc
also
influenc
influenza
life
cycl
replic
alveolar
macrophag
respiratori
tract
may
constitut
viral
sanctuari
sinc
antiretrovir
resist
mutat
may
found
sputum
individu
undetect
haartsuppress
viremia
besid
influenza
infect
trigger
pulmonari
inflammatori
respons
subsequ
home
monocyt
respiratori
tract
thu
increas
number
permiss
cell
coinfect
individu
cell
home
respiratori
tract
due
influenza
infect
may
also
harbor
latent
provir
genom
nucleu
thu
upon
activ
may
activ
produc
mention
retroviruswhich
could
potenti
increas
viral
load
respiratori
tract
activ
replic
respiratori
tract
occur
epitheli
cell
also
macrophag
despit
influenzainfect
macrophag
progeni
uninfecti
shown
elsewher
unabl
enter
within
epitheli
cell
viral
particl
solubl
glycoprotein
may
interact
surfac
via
tlr
could
trigger
ifn
depend
respons
culmin
increment
level
therefor
influenzainfect
cell
may
continu
expos
viral
particl
surfac
protein
respiratori
tract
coinfect
patient
thu
reason
evalu
impact
influenza
replic
result
epitheli
cell
expos
could
constitut
valuabl
model
get
insight
rel
benign
clinic
evolut
influenza
infect
patient
found
produc
ifnlik
effect
toward
influenza
replic
reveal
inhibit
influenza
replic
effect
influenza
life
cycl
could
toll
influenza
replic
decreas
viral
evolut
perhap
contribut
mild
clinic
symptom
observ
group
coinfect
individu
also
use
human
primari
macrophag
experiment
studi
macrophag
function
natur
reservoir
sustain
long
last
viru
replic
wherea
cell
nonpermiss
influenza
infecti
influenza
viru
enter
macrophag
viral
protein
synthet
infecti
progeni
made
initi
macrophag
suscept
influenza
may
allow
cell
act
like
trojan
hors
allow
antigen
present
via
class
mhc
therefor
orchestr
cellmedi
cytotox
antivir
respons
hand
hospit
due
influenza
infect
occur
due
symptom
sever
acut
respiratori
infect
sari
associ
enhanc
proinflammatori
respons
influenzainfect
macrophag
inde
observ
viru
titer
drop
time
inocul
human
primari
macrophag
support
notion
infecti
viru
progeni
gener
inocul
macrophag
infect
laemmli
buffer
lysat
subject
blot
assay
protein
band
repres
three
differ
assay
analyz
densitometri
use
imagej
softwar
arbitrari
unit
score
b
parallel
macrophag
infect
infect
moi
h
analyz
adsorpt
cell
wash
incub
lyse
buffer
analyz
penetr
cell
wash
h
monolay
cover
medium
temperatur
rais
h
buffer
ad
altern
temperatur
kept
h
buffer
ad
lysat
fraction
nuclear
nonnuclear
fraction
centrifug
rna
extract
fraction
quantifi
qrtpcr
rel
quantif
decreas
influenza
rna
level
mockinfect
macrophag
increas
influenza
rna
level
mockinfect
macrophag
influenza
viru
recov
cultur
supernat
significantli
smaller
supernat
macrophag
infect
also
found
enhanc
content
macrophag
propos
inhibit
influenza
replic
impair
arriv
viral
rnp
nucleu
fact
show
macrophag
rna
transloc
nucleu
reduceddelay
consequ
influenza
transcript
macrophag
attenu
phenomena
may
reduc
influenza
induc
tnfa
one
import
cytokin
releas
influenzainduc
cytokin
storm
therefor
imagin
chanc
cytokin
storm
coinfect
individu
would
also
reduc
could
contribut
surpris
mild
clinic
outcom
observ
group
risk
pandem
result
coinfect
macrophag
could
gain
even
substanti
mean
correl
clinicalhistolog
find
work
shieh
et
al
show
repres
immunohistochemistri
result
individu
deceas
due
influenza
infect
natur
observ
influenza
presenc
macrophag
respiratori
tract
moreov
cohort
individu
posit
correl
exist
retroviru
respiratori
tract
made
therefor
best
knowledg
clinicalhistolog
investig
coinfect
macrophag
aim
investig
conclus
collect
data
obtain
experiment
assay
clinic
sampl
bring
new
suggest
matur
virion
envelop
protein
may
reduc
replic
delay
evolut
viru
thu
contribut
attenu
clinic
cours
influenza
coinfect
patient
figur
measur
influenza
transcript
uninfect
macrophag
infect
influenza
cell
lyse
rna
extract
cdna
synthet
use
oligodt
primer
quantit
real
time
pcr
perform
gene
control
ribavirintr
untreat
influenzainfect
macrophag
submit
procedur
describ
inset
reduct
rna
level
increas
rna
level
n
figur
influenza
induct
tnfa
attenu
macrophag
macrophag
infect
coinfect
h
cell
wash
tnfa
level
measur
h
influenza
infect
decreas
tnfa
level
macrophag
coinfect
infect
vs
influenzainfect
macrophag
figur
puriti
rna
prepar
nuclear
extract
macrophag
lyse
buffer
centrifug
min
g
obtain
pellet
supernat
sn
contain
nuclear
nonnuclear
cell
fraction
respect
rna
fraction
extract
cdna
synthet
real
time
pcr
perform
comparison
correspond
white
black
bar
amplicon
detect
nd
whitin
cycl
indic
n
tif
figur
exposur
tat
effect
influenza
replic
hela
cell
expos
tat
oxid
tat
tatox
ifnc
h
rna
extract
cultur
supernat
influenza
viru
quantifi
qrtpcr
supernat
titter
mdck
b
ifnc
use
posit
control
asterisk
indic
statist
signific
control
medium
n
tif
hela
cell
expos
cultur
medium
treatment
ngml
ag
mgml
ifnc
ngml
h
influenza
infect
supernat
harvest
rna
extract
ha
gene
influenza
sequenc
presumpt
amino
acid
residu
analyz
b
clinic
sampl
influenza
patient
coinfect
onset
ill
detect
juli
th
august
th
southern
brazil
rio
de
janeiro
rna
extract
nucleotid
sequenc
put
amino
acid
sequenc
ha
analyz
tree
root
vaccin
strain
circl
indic
sampl
coinfect
individu
sequenc
ha
perform
sanger
method
phylogenet
tree
amino
acid
gener
program
mega
neighborjoin
algorithm
bootstrap
bootstrap
probabl
indic
interior
branch
scale
bar
indic
number
amino
acid
chang
per
site
figur
exposur
inhibit
influenza
replic
dosedepend
manner
hela
cell
expos
indic
input
ifnc
h
supernat
titter
mdck
ifnc
use
posit
control
asterisk
indic
statist
signific
control
medium
n
tif
figur
viabil
hela
cell
expos
hela
cell
expos
ngml
ag
mgml
ifnc
ngml
h
cell
viabil
measur
xtt
assay
n
tif
figur
grow
hela
cell
line
cell
lineag
hela
tzmbl
hela
background
express
among
gene
expos
ngml
ag
h
cell
wash
remov
unbound
virus
fresh
cultur
medium
ad
indic
day
infect
aliquot
cultur
supernat
collect
measur
ag
elisa
product
detect
nd
hela
cell
n
tif
figur
macrophag
nonpermiss
influenza
macrophag
infect
indic
moi
influenza
h
inocul
medium
serumfre
dmem
contain
serum
albumin
trypsin
mgml
cell
wash
remov
unbound
virus
fresh
inocul
medium
ad
indic
day
infect
aliquot
cultur
supernat
collect
titter
mdck
endpoint
dilut
tcid
ml
n
tif
